The present invention provides a pyrazole compound of the following general Formula [Ib] having SGLT1 inhibitory activity, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and its pharmaceutical use:
wherein each symbol is the same as defined in the description.
本发明提供了一种具有SGLT1抑制活性的下式[Ib]所示的
吡唑化合物、或其药物可接受的盐、包含该化合物的药物组合物及其医药用途:
其中每个符号如说明书中所定义。